NEWS

Texas judge suspends FDA approval of abortion pill, Washington judge responds with conflicting order

Updated: April 8, 2023 at 10:57 am EST  See Comments

Sat Apr 8, 2023 – 10:04 am EDTSat Apr 8, 2023 – 10:36 am EDT

(LifeSiteNews) — A federal judge in Texas has issued an order putting on hold the FDA’s approval of mifepristone, the first of the two abortion pills used in sequence for more than half of all US abortions. The order will go into effect on April 14.

The delayed effect of the order, issued on Friday, April 7 (Good Friday), was to allow time for the FDA to seek emergency relief from the Fifth Circuit Court of Appeal.

The order from Judge Matthew Kacsmaryk would apply to all 50 states, including those where abortion is currently legal. However, just two hours after Kacsmaryk issued his order, a different judge in the state of Washington made a conflicting Order requiring the abortion drug to remain on the market in the states of Washington, Oregon, Arizona, Colorado, Connecticut, Delaware, Illinois, New Mexico, Rhode Island, Vermont, Hawaii, Maine, Maryland, Minnesota, Michigan and the District of Columbia.

Kacsmaryk is a Trump administration appointee in Amarillo, Texas. The Washington judge, Spokane-based Judge Thomas O. Rice, is an Obama administration appointee.

It is noteworthy that the judge in

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Replacing Darwin - The New Origin of Species
By Dr. Nathaniel T. Jeanson
Buy Now Price: $24.99
Rated 4 out of 5
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.